MISSED THE 2022 FORUM? CLICK TO ACCESS THE SESSIONS >>

Event Overview

The Psychedelics
Business Forum

In partnership with

NOVEMBER 15th, 2022

At this exclusive one-day Psychedelics Business Forum, we heard from experts in Psychedelics covering a variety of topics including:

– The current state of Psychedelics
– Investment trends
– The latest research and how it relates to your business
– Commercialization timelines
– Indigenous inclusion and how to be an advocate
– Lessons learned from existing Psychedelics companies
– Conservation and much more

Passes start at $349

Thanks to our partners

SPONSORS
COMMUNITY PARTNERS
PBA - Final Identity TALL (2)
MEDIA PARTNERS

Agenda

Agenda

Join our exclusive one day forum bringing together some of the brightest minds in the industry for thoughtful and informational conversation

8:30-9:20

Breakfast & Networking

Enjoy breakfast and mingle with other guests


9:20-9:40

Welcome to the Psychedelics Business Forum

A greeting from the reMind team


9:40- 10:05

The New Psychedelics Era: Politics, Profit & Principles

What the business community needs to know about the opportunities — and responsibilities — that lie ahead


Ethan Nadelmann, Host, Psychoactive' podcast
10:05-10:40

Changing Lives: The Promise of Psychedelics

Depression, PTSD, addiction, end-of-life treatments: A breakdown of individual drugs and their medical potential


Lynn Marie Morski, President, Psychedelic Medicine Association
10:40- 11:00

How the Marketplace Will Evolve — Part 1

Policy changes, legal landscape, and recent election results


Ariel Clark, Principal, Clark Howell LLP
11:00-11:20

How the Marketplace Will Evolve — Part 2

Generational attitudes and habits are changing rapidly


Bethany Gomez, Managing Director, Brightfield Group
11:20-12:00

Cannabis & Psychedelics: Similar Story, Different Trajectory

Understanding the booms, busts, and other risks and opportunities ahead


Sean McAllister, Legal Pioneer, McAllister Law Office
Amanda Reiman, Chief Knowledge Officer at New Frontier Data, Founder at Personal Plants
David Heldreth, CEO, Panacea Plant Sciences
Ricardo Baca, CEO & Founder, Grasslands
12:00-01:00

Lunch & Networking


1:00-1:40

Capitalism & Consciousness: The Evolution of Business

How psychedelics can co-exist with the profit motive and develop ethically with indigenous culture


Dustin Robinson, Managing Principal Iter Investments
Troy Sia, Co-Founder, Sia the Piah Puha Kahni “Mother Church”
Liana Gillooly, Strategic Initiatives Officer, MAPS
Amanda Reiman, Chief Knowledge Officer at New Frontier Data, Founder at Personal Plants
1:40-2:30

Psychedelic Drug Discovery

Far more unknowns than knowns: Why our scientific explorations have only just begun


Jackie von Salm, Co-Founder & Chief Scientific Officer, Psilera
Benjamin Lightburn, CEO & Co-Founder, Filament Health
2:30-3:15

Investing in Psychedelics

How to evaluate the sectors, companies, and evolving landscape to identify opportunities


Simeon Schnapper, Managing Partner, JLS Fund
Scarlet Masius, Head of Community, Tactogen
Michael Huttner, CEO & Co-Founder, Next Titan Capital
Jeff Zuber, Founding Partner, Zuber Lawler
3:15-3:45

One Veteran’s Personal Journey

A combat veteran shares his experiences with psychedelics and PTSD


Neil Markey, CEO & Co-Founder, Beckley Retreats
3:45-4:30

The Future of Psychedelics: Entrepreneurial Perspectives

Ideas and advice from entrepreneurs across the psychedelics industry


Todd Shapiro, CEO, Red Light Holland
Sutton King, Program Manager Indigenous Medicine Conservation Fund
Chris Claussen, Chief Innovation Officer, First Person Group
Kelsey Ramsden, Advisory Board, reMind
Ronan Levy, Chairman & CEO, Field Trip Health
4:30-5:00

Zuber Lawler Cocktail Reception


Attendees

Join us!

Connect with the pioneers
of the psychedelics industry

reMind brings together innovative leaders in capital, policy, research, healthcare, culture, technology and education.
Connect with leaders, newcomers, and investors in the rapidly growing psychedelics industry.

Logo-Black

Join us!

Connect with the pioneers
of the psychedelics industry

reMind brings together innovative leaders in capital, policy, research, healthcare, culture, technology and education.
Connect with leaders, newcomers, and investors in the rapidly growing psychedelics industry.

Get Involved

Expand your network:
become a reMind sponsor

Interested in collaborating with reMind as a partner, advisor, presenter or sponsor? Complete the form below and a member of our team will be in touch.